Patents by Inventor Patrick Reichenbach

Patrick Reichenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kinase mutants and uses thereof
    Patent number: 11738049
    Abstract: The present invention relates to methods of designing kinase mutants for reprogramming the sensitivity of a target kinase to some specific inhibitors, methods of reprogramming the sensitivity of a target kinase to some specific inhibitors, wherein those kinase inhibitors have little or no affinity for the wild-type target kinase, vectors or cells expressing said mutated kinases, composition and uses thereof for the prevention and/or treatment of a disease or disorder, in particular cancer.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: August 29, 2023
    Assignees: SIB Swiss Institute of Bioinformatics, CHUV—Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Ludwig Institute for Cancer Research Ltd
    Inventors: Olivier Michielin, Vincent Zoete, George Coukos, Melita Irving, Nahzli Dilek, Patrick Reichenbach, Kelly Ascencao
  • KINASE MUTANTS AND USES THEREOF
    Publication number: 20200101110
    Abstract: The present invention relates to methods of designing kinase mutants for reprogramming the sensitivity of a target kinase to some specific inhibitors, methods of reprogramming the sensitivity of a target kinase to some specific inhibitors, wherein those kinase inhibitors have little or no affinity for the wild-type target kinase, vectors or cells expressing said mutated kinases, composition and uses thereof for the prevention and/or treatment of a disease or disorder, in particular cancer.
    Type: Application
    Filed: May 24, 2018
    Publication date: April 2, 2020
    Inventors: Olivier Michielin, Vincent Zoete, George Coukos, Melita Irving, Nahzli Dilek, Patrick Reichenbach, Kelly Ascencao
  • Human est1 gene
    Publication number: 20040171000
    Abstract: The invention provides an isolated, enriched, purified or recombinant nucleic acid sequences (EST1) and proteins encoded thereby having activity as telomerase activity modulators. The invention also provides methods for screening for agents having mammalian telomerase modulating activity.
    Type: Application
    Filed: November 21, 2003
    Publication date: September 2, 2004
    Inventors: Joachim Lingner, Patrick Reichenbach, Matthias Hoss, Markus Nabholz, Philipp Bucher